₹1.25
(Market cap
₹10 Cr
Revenue (TTM)
₹15 Cr
P/E Ratio
9.2
P/B Ratio
2.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
13.9 %
-
ROCE
18.1 %
-
Industry P/E
40.32
-
EV/EBITDA
6.1
-
Debt to Equity
0
-
Book Value
₹10.2
-
EPS
₹2.3
-
Face value
10
-
Shares outstanding
4,480,500
10 Years Aggregate
CFO
₹1.50 Cr
EBITDA
₹3.83 Cr
Net Profit
₹2.75 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Unjha Formulations
| -15.0 | 8.7 | -7.4 | -14.9 | 15.1 | 21.3 | 6.1 |
|
BSE Healthcare
| 7.1 | 11.7 | 10.9 | 10.9 | 26.2 | 14.1 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Unjha Formulations
| -18.4 | 77.6 | 6.2 | 42.0 | 22.5 | 15.3 | -6.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Unjha Formulations
|
21.3 | 9.5 | 14.9 | 1.0 | 7.8 | 27.8 | 9.2 | 2.1 |
| 2,734.3 | 22,376.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 62.8 | 13.5 | |
| 3,035.0 | 37,883.0 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 35.9 | 8.4 | |
| 8,493.0 | 21,223.1 | 2,177.5 | 200.9 | 11.3 | 26.5 | 105.6 | 25.5 | |
| 1,643.0 | 31,123.0 | 9,203.5 | 941.3 | 15.4 | 19.6 | 33.7 | 6.3 | |
| 2,149.8 | 34,550.6 | 4,193.0 | 753.8 | 22.7 | 20.8 | 45.8 | 8.6 | |
| 1,835.2 | 21,047.8 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1047.1 | 3.6 | |
| 4,818.8 | 22,009.5 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.8 | 5.5 | |
| 179.9 | 23,893.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 1,606.5 | 26,110.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.6 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Unjha Formulations
Unjha Formulations Limited manufactures and sells ayurvedic products in India. The company offers sat-isabgol and isabgo husk formulation in elaichi flavor under the Anchor name; and isabgol powder in orange flavor under the Fibron and Fibron SF... names, as well as natural fiber drink products. It also exports its products. The company was incorporated in 1994 and is based in Sidhpur, India. Read more
-
Incorporated
1994
-
Chairman
Jashodaben S Patel
-
Managing Director
Krutiben M Patel
-
Headquarters
Sidhpur, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Unjha Formulations
What is the current share price of Unjha Formulations Ltd Today?
The share price of Unjha Formulations Ltd is ₹21.26 (BSE) as of 08-May-2026 IST. Unjha Formulations Ltd has given a return of 15.13% in the last 3 years.
What is the current PB & PE ratio of Unjha Formulations Ltd?
The P/E ratio of Unjha Formulations Ltd is 9.17 times as on 08-May-2026, a 77 discount to its peers’ median range of 40.32 times.
The P/B ratio of Unjha Formulations Ltd is 2.08 times as on 08-May-2026, a 62 discount to its peers’ median range of 5.42 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.99
|
3.11
|
|
2024
|
30.47
|
3.10
|
|
2023
|
19.83
|
2.28
|
|
2022
|
16.66
|
1.94
|
|
2021
|
36.78
|
1.99
|
What is the 52 Week High and Low of Unjha Formulations Ltd?
The 52-week high and low of Unjha Formulations Ltd are Rs 30.40 and Rs 18.60 as of 08-May-2026.
What is the market cap of Unjha Formulations Ltd?
Unjha Formulations Ltd has a market capitalisation of ₹ 10 Cr as on 08-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Unjha Formulations Ltd?
Before investing in Unjha Formulations Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.